90532-02-8 Usage
General Description
The chemical compound (4-Bromo-3-methylphenyl)(methyl)sulphane is an organosulphur compound with a molecular formula C8H9BrS. It consists of a benzene ring with a methyl group and a bromine atom attached, as well as a methylsulphane group. (4-Bromo-3-methylphenyl)(methyl)sulphane is commonly used in organic chemistry as a reagent for various reactions, including the synthesis of other organosulphur compounds. It is also known for its potential pharmaceutical and biological applications due to its unique chemical properties. Additionally, (4-Bromo-3-methylphenyl)(methyl)sulphane is considered to be a stable and relatively safe compound when handled and stored properly.
Check Digit Verification of cas no
The CAS Registry Mumber 90532-02-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,5,3 and 2 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 90532-02:
(7*9)+(6*0)+(5*5)+(4*3)+(3*2)+(2*0)+(1*2)=108
108 % 10 = 8
So 90532-02-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H9BrS/c1-6-5-7(10-2)3-4-8(6)9/h3-5H,1-2H3
90532-02-8Relevant articles and documents
NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS
-
Paragraph 0352-0353, (2020/11/03)
Disclosed are compounds of formula (I) or (II) that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
PRC2 INHIBITORS
-
Paragraph 0302-0303, (2019/08/26)
The present invention relates to compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention. (Formula (I))
IMIDAZOPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER
-
Paragraph 00226, (2018/04/12)
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R3, R4, R6, and R7 are as defined herein.